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Granzyme BThe impairment of humoral immune response in elderly humans has been extensively demonstrated. We have re-
ported the increase of memory B cells (IgG+IgD−CD27−, double negative, DN) population in the elderly, in which
there is also a typical inﬂammatory micro-environment. In order to evaluate whether this pro-inﬂammatory status
could inﬂuence the trafﬁcking phenotype of naïve/memory B cells, we have assessed the expression of CCR7, CCR6,
CXCR3, CXCR4, CXCR5 and CD62L on naïve/memory B cell subpopulations in young and elderly subjects. Moreover,
the combination of pro-inﬂammatory interleukin-21 (IL-21) and B cell receptor (BCR) stimulation enables B cells to
produce and secrete granzyme B (GrB), which plays a critical role in early anti-viral immune responses, in the
regulation of autoimmune mechanisms and in cancer immunosurveillance.
Our data demonstrate that in the elderly, naïve/memory B cell populations present a different expression of the
studied receptors that could be discussed in terms of “inﬂamm-aging”. In particular IgG+IgD−CD27− DN B cells
show a tissue trafﬁcking phenotype and they can be stimulated to produce GrB.
© 2013 Elsevier Inc. All rights reserved.1. Introduction
B lymphocytes represent the humoral arm of adaptive immune
response. The defects in B cell production/development cause a variety
of disorders that are the basis of immune deﬁciencies and/or autoim-
mune diseases (Blair et al., 2010; Mauri, 2010; Vitale et al., 2010). For
this reason the deep knowledge of B cell subsets and functions provides
crucial information on immune assessment. Moreover B lymphocytes,
due to their ability to present antigen to T lymphocytes, produce
cytokines and synthesize granzymes, are now recognized as eclectic and
essential cells for an exhaustive immune response (Blair et al., 2010;
Bouaziz et al., 2010; Buffa et al., 2011; Hagn and Jahrsdörfer, 2012;
Hagn et al., 2009, 2012; Mauri, 2010; Vitale et al., 2010). The different B
cell subsets have been identiﬁed using many cellular markers by which
many functional subsets, as transitional, naïve, memory and plasmablasts
may be recognized. In particular IgD, CD27, CD24 and CD38, other than
other molecules, may be used to study peripheral B cells in humans.
Nevertheless “core” subsets may be identiﬁed by using IgD and CD27 ex-
pression on CD19 B cells and this kind of classiﬁcation has been suggested
to be useful as potential biomarkers in some autoimmune diseases
(Kaminski et al., 2012).ogy and Medical and Forensic
y 211, Palermo 90134, Italy.
G. Colonna-Romano).
ghts reserved.It is well known that the impairment of the immune system in the
elderly (immunosenescence) has been related to the increased suscep-
tibility to infectious diseases, cancer and autoimmunity; moreover,
immunosenescence also involves the B cell branch (Bulati et al., 2011;
Cancro et al., 2009; Frasca and Blomberg, 2011; Frasca et al., 2004,
2010, 2011; Schenkein et al., 2008), although most of the studies con-
sider the T lymphocytes (Ouyang et al., 2003; Pawelec and Larbi,
2008; Pawelec et al., 2005). In particular, in the elderly, we have demon-
strated the reduction, in percentage but not in absolute number, of
naïve B lymphocytes (IgD+CD27−) and the increase in percentage of
a “Double Negative” (DN, IgD−CD27−IgG+) memory B cell population
(Colonna-Romano et al. 2009). DN B cells have also been reported to
be expanded in patients affected by SLE, HIV and challenged with RSV
(Cagigi et al., 2009; Fecteau et al., 2006; Sanz et al., 2008; Wei et al.,
2007).
The increase in percentage of the DN B cell population in the elderly
might be related to the typical inﬂammatorymicro-environment, charac-
terized by a general increase in plasma levels of pro-inﬂammatory cyto-
kines and other inﬂammatory mediators (inﬂamm-aging) (Franceschi
et al., 2007; Licastro et al., 2005; Singh and Newman, 2011; Vasto et al.,
2007). As it is known that the absolute number of B cells is signiﬁcantly
reduced in the elderly, the proportional increase of the DN B cell popula-
tionmight be due to the exhaustion ofmemory B lymphocytes chronical-
ly stimulated in the elderly (Colonna-Romano et al., 2009). On the other
hand, it has also been reported that these cells can be stimulated
“in vitro” to secrete immunoglobulins against tetanus toxoid and inﬂuen-
za virus (Wirths and Lanzavecchia, 2005), although their ability to be
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Romano et al., 2009; Hao et al., 2011).
In the present paper in order to evaluate whether the inﬂammatory
milieu inﬂuences the B cell trafﬁcking, we have assessed the expression
of some chemokine receptors on the four subsets of B cells. Indeed
certain combination of chemokines and their receptors guides all the im-
mune cells to speciﬁc tissues (Kunkel and Butcher, 2003). Concerning B
cells it has been demonstrated that CXCR4, CXCR5, CCR6 and CCR7 drive
them to lymph node, while CXCR3 leads B cells to sites of inﬂammation
(Kunkel and Butcher, 2003). More recently (Kaminski et al., 2012), the
chemokine receptor CXCR3 has been found to be expressed on DN B
cells as additional marker, and the expression of CXCR3 might be consis-
tent with migration of cells to chronically inﬂamed tissues (Moir et al.,
2008). We have also evaluated the expression of the homing molecule
CD62L that is involved in the homing of naïve lymphocytes to peripheral
lymph nodes and Peyer's patches. CD62L mediates the tethering and
rolling of leukocytes on endothelial surfaces, contributing to the recruit-
ment of leukocytes from the blood to areas of inﬂammation.
It has been recently shown that interleukin-21 (IL-21), produced by
various subsets of activated CD4+ T cells, NKT and Th17 cells (Spolski
and Leonard, 2008), other than regulatingmultiple innate and adaptive
immune responses can stimulate immune cells to synthesize various
inﬂammatory molecules. Moreover, excessive production of IL-21
has been described in many human chronic inﬂammatory disorders
and there is evidence supporting the pathogenic role of IL-21 in
immune-inﬂammatory pathologies (Sarra et al., 2013). It has also been
reported that IL-21 levels are increased in healthy elderly (Agrawal
et al., 2012).
In the present paper, we show a different expression of chemokine
receptors on DN B cells from the elderly andwe also show that the abil-
ity to produce granzyme B under the control of IL-21 (Hagn and
Jahrsdörfer, 2012; Hagn et al., 2009; Hagn et al., 2012) is not impaired
in B cells obtained from old subjects; moreover, DN B cells seem to be
sensitive to the action of IL-21 that, as mentioned (Agrawal et al.,
2012), is increased in the elderly.
2. Materials and methods
2.1. Subjects
Forty healthy Sicilian subjects were studied, 20 young (age range
25–40 years) and 20 elderly (age range 78–90 years). None of the
selected subjects had neoplastic, infectious, autoimmune diseases, or re-
ceived any medications inﬂuencing immune function at the time of the
study. All subjects gave informed consent according to the Italian law.
2.2. Cell preparation and B cell enrichment
Peripheral blood mononuclear cells (PBMCs) were isolated from ve-
nous blood by density gradient centrifugation on Ficoll–Lympholyte
(Cedarlane Laboratories Limited, Ontario, Canada). PBMCs were adjusted
to 1 × 106/ml in RPMI 1640 medium (Euroclone, Devon, UK) supple-
mented with 10% heat-inactivated fetal bovine serum (FBS) (Euroclone),
1% penicillin/streptomicin, 10 mM HEPES, and 1 mM L-glutamin. B
lymphocytes were separated from PBMCs by immunomagnetic sorting,
as described by Miltenyi et al. (1990) using anti-CD19 magnetic
microbeads (MACS CD19 Multisort Microbeads, Miltenyi Biotec, Aubum,
CA, USA). Cells obtained from immunomagnetic sorting were N98%
CD19+ lymphocytes, as determined by ﬂow cytometry analysis.
2.3. Antibodies and ﬂow cytometry panels
Puriﬁed B cells were stained with different combinations of the fol-
lowing monoclonal antibodies: anti-IgDFITC or anti-IgDAPC, anti-CD27PE
or anti-CD27APC, anti-CD196PE (CCR6), anti-CD197PE (CCR7), anti-
CD62LPE, anti-CD183APC (CXCR3), anti-CD184PE (CXCR4, Fusin), anti-GrBFITC, anti-CD185PE-Cy7 (CXCR5) (BD, Pharmingen). Cells were washed
twice and analyzed. All measurements were made with a FACSCalibur
ﬂow cytometer (Becton Dickinson, San Jose, CA, USA) with the same in-
strument setting. At least 104 cells were analyzed using CellQuestPro
(Becton Dickinson, San Jose, CA, USA) or FlowJo (Tree Star) software.
2.4. Reagents for functional assays
For ﬂow cytometric intracellular GrB detection, magnetically sorted
B cells were cultured in AIM-V medium (Invitrogen) at 1 × 106/ml for
16 h and incubated at 37 °C and 5% CO2 atmosphere in the presence/
absence of both recombinant human IL-21 (Gibco®, Life Technologies),
used at a ﬁnal concentration of 50 ng/ml, and, for Ag-independent BCR
stimulation (anti-BCR), afﬁniPure F(ab′)2 fragment goat anti-human
IgG, F(ab′)2 fragment speciﬁc (Jackson ImmunoResearch Laboratories)
at 6.5 μg/ml. Brefeldin A (Biolegend) was added to a ﬁnal concentration
of 1 μg/ml, and cells were cultured for four more hours (Hagn et al.,
2009). At the indicated time point, cells were harvested, washed and
stainedwith anti-CD27PE and anti-IgDAPC. Intracellular stainingwasper-
formed using a ﬁxation and permeabilization buffer (Fix & Perm cell
permeabilization kit, Invitrogen). Brieﬂy, cells were washed and resus-
pended in ﬁxation buffer, incubated for 15 min at room temperature,
and washed with PBS/FCS 5%. Cells were then resuspended in perme-
abilization buffer and anti-GrBFITC was added. After another 20 min of
incubation at room temperature, cells were washed with PBS/FCS 5%.
Flow cytometric analyses were performed on a FACSCalibur ﬂow
cytometer (Becton Dickinson, San Jose, CA, USA) and data were
analyzed using FlowJo software (Tree Star).
2.5. Statistical analysis
Values are given asmedian and range ofmeanﬂuorescence intensities
(MFI) and are compared using Mann–Whitney nonparametric U test.
Differences are considered signiﬁcantwhenapvalue b 0.05wasobtained
by comparison between the different groups.
3. Results
3.1. Proﬁle of trafﬁcking receptors in B cell subpopulations
In order to evaluate the trafﬁcking phenotype of naïve/memory B
cells in the different age groups, we have assessed the expression of
CCR7, CCR6, CXCR3, CXCR4, CXCR5, and CD62L on B cell populations
identiﬁed on the basis of the different expression of CD27 and IgD in
young (Y) and elderly (O) subjects (Table 1).
Concerning the expression of CCR7 on DN cells, we report that DN B
cells obtained from elderly donors show signiﬁcant increase of this
chemokine receptors when compared with the expression evaluated in
the same cells obtained from the young group. Besides CCR7 expression
is differently modulated in young and in elderly donors as shown by the
different median values in the four populations in both age groups.
As reported by others (Kunkel and Butcher, 2003), CCR6 is mainly
expressed on naïve B cells from healthy adult subjects. We conﬁrm
these results in our young donors, moreover we demonstrate a high ex-
pression of this receptor onmemory unswitched cells too,whereasmem-
ory switched andDNB cells express very low levels of CCR6. In the elderly
group, CCR6 is differently modulated and, as a median value, it is
expressed at signiﬁcantly higher levels on memory switched and DN B
cells.
Concerning CXCR3, in young donors this is expressed at higher
signiﬁcant levels on memory unswitched and on DN B cells comparing
to the other populations of the same group. Differently, in the elderly
higher levels of CXCR3 are observed only on memory unswitched and
not in DN B cells.
As reported (Kunkel and Butcher, 2003), CXCR4 is mainly expressed
on naïve B cells. Here we show that it is also expressed on memory
Table 1
Expression of trafﬁcking receptors on B cell subpopulation, identiﬁed by the “core”markers IgD and CD27, of young and elderly donors. Values are expressed as median and range (P25–
P75) of mean ﬂuorescence intensities (MFI). NS = not signiﬁcant. In bold are expressed the signiﬁcant p values.
Subjects Naïve (IgD+CD27−) Memory unswitched (IgD+CD27+) Memory switched (IgD−CD27+) Double negative (IgD−CD27−)
Young 99.1 (82.8–126.7) 69.1 (48.5–78.2) 9.9 (8.8–11.5) 10.3 (9–14.5) CCR7
Old 45.5 (30–71.3) 79 (33.9–104) 14 (13.1–18.4) 38 (24.7–55.3)
p Young vs Old NS NS NS 0.005
Young 163.4 (51.1–278.8) 113.8 (60.6–167.2) 24 (20.4–26) 22.7 (15.4–33.7) CCR6
Old 60.2 (51.9–76.5) 51.1 (50.7–64.3) 43.3 (20–67.4) 86.1 (21.7–176.8)
p Young vs Old 0.02 0.03 0.01 0.02
Young 62.2 (50.2–68.8) 141.6 (135.2–147.2) 67.8 (49.7–86.7) 136.2 (78.9–241) CXCR3
Old 50.4 (44.1–52.8) 245.9 (112.6–278.3) 61.8 (56.2–67.2) 67.6 (60.2–71.3)
p Young vs Old NS 0.02 NS 0.01
Young 39.9 (31.4–46.8) 49 (32.9–93.2) 20.1 (13.9–27.1) 16.9 (15.1–18.9) CXCR4
Old 73.4 (49.6–102.8) 78.2 (31.3–140.4) 26.5 (23.2–29.5) 33.6 (24.3–36.5)
p Young vs Old 0.03 NS NS NS
Young 34.9 (29.2–73.2) 230.3 (119.4–241.1) 49 (47.8–51.5) 26.1 (19–37.7) CXCR5
Old 26.6 (23.5–55.6) 220.5 (78.9–231.1) 46.2 (40.5–60.3) 24 (22.7–33)
p Young vs Old NS NS NS NS
Young 69.3 (52.6–90.1) 93.4 (76.5–117.4) 115.7 (91.2–145.1) 77.5 (69.4–82.6) CD62L
Old 145 (82–201.7) 278 (127.3–343) 389.5 (133.6–417.8) 133.6 (75.2–149)
p Young vs Old 0.05 0.05 0.05 0.05
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on memory switched and DN B cells. No signiﬁcant differences are
observed between young and old subjects except for the naïve cells
(O N Y).
CXCR5 is mainly expressed on memory unswitched B cells, whereas
we observe a signiﬁcant reduction of CXCR5 expression on memory
switched and a very low expression on naïve and DN B populations ob-
tained from both age class donors. Moir et al. (2008), show the higher
level of CXCR5 expression on naïve B cells, but they identify this
population using different phenotypical markers (CD21HighCD27−).
Concerning the expression of CD62L on the four different B cell pop-
ulations (from young donors) we observe the higher expression on
switched memory. The same feature is observed on B cells from elderly
donors, although themedian value ofMFI is signiﬁcantly higher on cells
from the elderly compared to that from young subjects.
Table 2 shows, on thewhole, the trafﬁcking receptor phenotype of the
four B cell populations in young and elderly donors. As expected, naïve
andmemory unswitched B cells have a “lymph node phenotype”, where-
as memory switched express molecules useful to leave the lymphoid or-
gans. Memory unswitched and DN B cells from young subjects show also
high levels of CXCR3, a chemokine receptor that leads cells to site of in-
ﬂammation (Henneken et al., 2005; Kunkel and Butcher, 2003; Stein
and Nombela-Arrieta, 2005). In B cells from elderly donors this receptor
is well expressed only on memory unswitched subpopulation. Notably,
memory switched and DN B cells of elderly donors express CCR6 which
is also involved for the recruitment of cells in the site of inﬂammation
(Comerford et al., 2010; Othani et al., 2011; Welsh-Bacic et al., 2011;
Williams, 2006). DN B cells from elderly donors also express CCR7.
3.2. DN B cells produce GrB after IL-21-stimulation and BCR engagement in
the absence of CD40 ligation
In order to evaluatewhether total B cells andDNmemory B lympho-
cytes are able to act as GrB producing cells, we have investigated their
ability to respond to the simultaneous in vitro stimulation with IL-21Table 2
Homing/trafﬁcking receptor phenotype of the four B cell subpopulation in young and elderly d
B cell subpopulation Phenotype of trafﬁcking recepto
Young
Naïve (IgD+CD27−) CCR7+CCR6+CXCR4+
Memory unswitched (IgD+CD27+) CCR7+CCR6+CXCR3+CXCR4+C
Memory switched (IgD−CD27+) CXCR5dimCD62L+
Double negative (IgD−CD27−) CXCR3+and the triggering of BCR with anti-human IgG, in young and elderly
subjects. As shown in Fig. 1, after stimulation, both in young and elderly
people, total B cells (Fig. 1A) produce GrB when compared to the not
stimulated cells without differences between the two groups. Next
(Fig. 1B), we focused on DN B cells, observing that also this particular
memory population, under the same condition, shows GrB production
ability without differences between the two age groups studied. In
Fig. 1C and D we report a typical experiment in which we show the ca-
pacity of total B cells and IgD−CD27− (DN) B lymphocytes, obtained
froman elderly donor, to produce GrB after IL-21 andα-IgG stimulation.
4. Discussion
It is well known that with aging, the levels of inﬂammatory media-
tors increase even in the absence of acute infection or other stressors
(Singh and Newman, 2011). This situation, characterized by a general
increase in plasma levels of pro-inﬂammatory cytokines, leads to a
chronic, low-grade, pro-inﬂammatory status known as “Inﬂamm-aging”
(Franceschi et al. 2007; Salvioli et al., 2013). There is a common con-
sensus in the scientiﬁc community that ascribes the cause and/or the
consequence of many aspects of senescence to the increased baseline
inﬂammatory status in elderly people. It is also known that the impair-
ment of the adaptive immune system in the elderly involves not only
the widely studied T cell branch (Ouyang et al., 2003; Pawelec and
Larbi, 2008; Pawelec et al., 2005), but also the humoral arm (Bulati
et al., 2011; Cancro et al., 2009; Frasca and Blomberg, 2011; Frasca
et al., 2004; Schenkein et al., 2008). These changes include shifts in
themagnitude of all B cell compartments, speciﬁcity repertoire changes,
modiﬁed peripheral B cell dynamics, and weakened humoral responses
(Aberle et al., 2013; Bulati et al., 2011; Faria et al., 2008; Frasca et al.,
2008). Using the “core markers” IgD and CD27 (Kaminski et al., 2012),
we have also demonstrated the increase of a DN (IgD−CD27−IgG+)
B cell population (Colonna-Romano et al. 2009) that has also been
shown to be increased in patients affected by SLE, HIV or in healthy
subjects challenged with RSV (Cagigi et al., 2009; Fecteau et al., 2006;onors.
rs
Elderly
CCR7+CCR6+CXCR4+
XCR5+CD62L+ CCR7+CCR6+CXCR3+CXCR4+CXCR5+CD62L+
CCR6+CXCR5dimCD62L+
CCR7+CCR6+
Fig. 1. IL-21 and BCR engagement induce GrB in total human CD19+ B cells and in IgD−CD27− (DN) B lymphocytes. Magnetically sorted B cells or IgD−CD27− (DN) B lymphocytes were
cultured in AIM-V medium for 16 h and incubated in the presence/absence of both recombinant human IL-21 (50 ng/ml) and afﬁniPure F(ab′)2 fragment goat anti-human IgG, F(ab′)2
fragment speciﬁc (6.5 μg/ml). Brefeldin A (1 μg/ml) was added and cells cultured for four more hours. (A) Production of GrB before (medium) and after stimulation (IL-21/α-IgG) by
CD19+ B cells in young and elderly donors. No signiﬁcant differences were observed between the two age-groups studied. (B) Production of GrB before (medium) and after stimulation
(IL-21/α-IgG) by IgD−CD27− (DN) B lymphocytes in young and elderly donors. No signiﬁcant differenceswere observed between the two age-groups studied. (C) Theﬁgure illustrates an
example of Zebra plot that shows the percentage of GrB+ total B cells in old subjects before (left panel) and after stimulation (right panel). (D) The ﬁgure illustrates an example of Zebra
plot that shows the percentage of GrB+ IgD−CD27− (DN) B lymphocytes in old subjects before (left panel) and after stimulation (right panel). We have performed these analyses on 10
young and 10 elderly subjects.
126 M. Bulati et al. / Experimental Gerontology 54 (2014) 123–129Sanz et al., 2008; Wei et al., 2007). This DN population seems to be an
“exhausted” memory population (Buffa et al., 2011; Bulati et al., 2011;
Colonna-Romano et al., 2009), although it has also been demonstrated
that these cells may be stimulated to secrete immunoglobulins (Wirths
and Lanzavecchia, 2005). A similar population has recently been identi-
ﬁed by Hao et al. (2011) in elderly mice.
A link between “Inﬂamm-aging” and adaptive immune responses
may be identiﬁed in the expression of chemokine receptors. The rele-
vance of chemokine receptors is doubtless suggested by the knowledge
that, although there is much promiscuity within the chemokine net-
work, certain combinations of chemokines and their receptors guide
all the immune cells, and also B cells, to speciﬁc tissues (Kunkel and
Butcher, 2003). Accordingly, CXCR4, CXCR5, CCR6 and CCR7 have been
identiﬁed as receptors that drive B cells to lymph node attracted by a
combination of CXCL12, CXCL13, CCL20 and CCL19 respectively, while
CXCR3 leads B cells to sites of inﬂammation (Kunkel and Butcher,
2003). Indeed, as known, the CXCR3 ligands, monokine-induced by
Interferon-γ (CXCL9) and IP10 (CXCL10), are widely expressed by the
endothelium and other cells in inﬂamed tissues (Farber, 1997), indicat-
ing that B cells that express CXCR3 can directly enter these inﬂamed
sites. Expression of CXCR4, CXCR5, CCR6 and CCR7 has been reported
on circulating naïve and memory B cells (Caraux et al., 2010), although
many authors report the involvement of CCR6 in the recruitment in sites
of inﬂammation (Comerford et al., 2010; Schutyser et al., 2003; Welsh-
Bacic et al., 2011).
Our data show a different expression of these chemokine receptors
on peripheral naïve andmemory B cells from young and old donors. In-
deed, as expected, in young donors naïve B cells express CCR7, CCR6 and
CXCR4 allowing B cells to circulate. Thereafter they (both memory
unswitched and memory switched) modulate the expression of CD62L
and CXCR5 necessary to cooperate with T cells in lymphoid organs.
Memory unswitched cells also express CXCR3, the chemokine receptor
that consents cells to reach the inﬂammatory sites. This chemokine re-
ceptor is the sole expressed in the DN B population in young people.
So, it seems that both memory unswitched and DN B cells are able tomigrate into the inﬂamed sites in a common ﬂogistic reaction. With
aging, naïve/memory B cell populations show some modiﬁcations on
the expression of the studied receptors. Indeed, due to their expression
of CXCR3, memory unswitched B cells retain the capacity to migrate to
the sites of inﬂammation, while double negative B cells lose the expres-
sion of this molecule, but express CCR6 and CCR7, i.e. chemokine recep-
tors, which are also implicated in the migration to the inﬂammatory
sites (Comerford et al., 2010; McNamee et al., 2013; Welsh-Bacic et al.,
2011), as described below.
These data are interesting and can be discussed in terms of
“inﬂamm-aging”. Our hypothesis is that the inﬂammatory environment,
typical of aging, in someway changes the trafﬁcking ability of B cells and
renders them more sensitive both to the cytokines and the pro-
inﬂammatory molecules which are over-produced in the elderly
(Salvioli et al., 2013; Singh and Newman, 2011). Concerning CCR6, this
chemokine receptor only binds CCL20, which is produced by a variety of
epithelial cell types, as keratinocytes, pulmonary and intestinal epithelial
cells (Iwasaki and Kelsall, 2000; Nakayama et al., 2001; Reibman et al.,
2003) and can be strongly induced by pro-inﬂammatory signals such as
cytokine (TNF-α) and Toll-like receptor ligands (Schutyser et al., 2003).
The ligand/receptor pair CCL20/CCR6 is responsible for the chemo-
attraction of immature dendritic cells (DC), effector/memory T and B
cells and plays a role in various human pathologies, including cancer,
rheumatoid arthritis (Schutyser et al., 2003) and other autoimmune dis-
eases (Comerford et al., 2010). Given that CCL20 is expressed in different
tissues in resting condition and that it mediates themigration of a variety
of leukocyte subsets in vitro (Casamayor-Pallejà et al., 2002; Liao et al.,
2002; Vanbervliet et al., 2002), it is now clear that CCR6 and CCL20 only
play a limited role in homeostatic lymphocyte trafﬁcking in the periphery,
but contribute more to homing of leukocytes to the intestinal epithelium,
a tissue that displays characteristics of chronic inﬂammation (Comerford
et al., 2010). New evidences suggest that the CCR6/CCL20 axis provides
key homing signals for adaptive immune system cells, such as Th17
and Treg cells. Inﬂammatory T and B cells, neutrophils and monocytes
may also be recruited by virtue of CCR6 expression, leading to the
127M. Bulati et al. / Experimental Gerontology 54 (2014) 123–129development of inﬂammatory responses (Comerford et al., 2010). Fur-
thermore, CCR6 is also involved in the recruitment of CCR6-expressing
B cells to the follicle-associated epithelium, Peyer's Patches and isolated
lymphoid follicles (Williams, 2006). Moreover, other authors (Welsh-
Bacic et al., 2011) show that CCR6 and the corresponding ligand
CCL20 might be involved in the recruitment of T and B cells to form or-
ganized nodular inﬁltrates in chronic renal inﬂammation.
DN B cells from old donors also express CCR7 that is involved in the
cognate interaction between B and T cells (Reif et al., 2002). At now, we
might only speculate on this result as a role of the CCR7/CCL19/CCL21
chemokine axis in the development of tertiary lymphoid tissue (TLT),
has been recently demonstrated in the chronically inﬂamed intestine
of a mouse model of Crohn's-like ileitis (McNamee et al., 2013). More-
over the involvement of CCR7 and its ligands has been also shown in
other autoimmune and infectious diseases, such as rheumatoid arthritis,
Helicobacter pylori-induced gastritis, and Sjögren's syndrome (Müller
and Lipp, 2003).
These data suggest that that DN B cells, which are increased in old
subjects, are in some way involved in the inﬂamm-aging and that they
might be either a by-product of systemic inﬂammation or might be
directly involved in the immune response against pathogens. In this
perspective, we have searched for a functional role of these cells in the
inﬂammatory processes. Recently, it has been demonstrated that the
combination of the pro-inﬂammatory interleukin-21 (IL-21) and B cell
receptor (BCR) stimulation enables B cells to produce and secrete the
active form of the cytotoxic serine protease granzyme B (GrB), that,
even if it is not accompanied by the production of perforin, as in Natural
Killer (NK) and Cytotoxic T lymphocytes, plays a critical role in early
anti-viral immune responses, in the regulation of autoimmune mecha-
nisms and in cancer immunosurveillance (Hagn and Jahrsdörfer,
2012). Moreover, recent studies have revealed an increase of IL-21
levels in the elderly (Agrawal et al., 2012) and in SLE patients (Dolff
et al., 2011) in which we and other groups (Colonna-Romano et al.,
2009; Sanz et al., 2008; Wei et al., 2007) have shown the increase of
DNB cell population. In order to evaluatewhether DNB cells are also in-
volved in IL-21-mediated immune response, we tested the capacity of
these cells to produce GrB. In our experiments, we show no differences
of total B cells to produce GrB between young and elderly subjects, afterFig. 2.The “intriguing scenario” of theDNB cells in the inﬂamed tissue. Properly stimulated, DNB
expression), but herein they exert their function producing GrB (upper side of the ﬁgure). In the
inﬂammatory sites by the expression of other chemokine receptors (CCR6 and CCR7) involvedstimulation with human recombinant IL-21 and anti-human IgG. Inter-
estingly, we also observed that this kind of stimulation renders DN B
lymphocytes able to produce GrB, although, again, without any differ-
ence between the two age groups. These are intriguing data especially
if we consider what we have previously discussed about the chemokine
receptor proﬁle of DN cells that suggest their ability to migrate into the
inﬂamed tissues in different ways in young (by CXCR3 expression) and
in elderly donors (expression of CCR6 and CCR7). Although GrB produc-
tion and secretion are not prerogative of only a speciﬁc B cell popula-
tion, and naïve/memory B cells participate in all the phases of the
inﬂammatory responses, in this work our attention was caught by
CD19+IgG+IgD−CD27− memory population. Indeed, DN B lympho-
cytes, that show different pro-inﬂammatory trafﬁcking proﬁles, in
young and elderly subjects, are able, if properly stimulated, to migrate
into inﬂammatory sites, and, cooperating with other immune cells
(e.g. memory unswitched B cells), to produce GrB. With aging, there
is, other than an increase in percentage of DN B cells, also a remodeling
of these cells, probably due to the typical pro-inﬂammatory milieu of
the aged people. Indeed, in the elderly, DN B lymphocytes express a
different chemokine receptor proﬁle that, however, renders them able
to reach chronic inﬂamed tissues or tertiary lymph node. Moreover, as
their capacity to produce GrB is not impaired, they behave as in the
young (Fig. 2) exerting a biological function. Finally, DN B cells, in the
same or in different behavior conditions, could produce other kinds of
pro- or anti-inﬂammatory molecules, as cytokines. So, it is important
to improve the study on DN B cells to better understand their active
role in immunosenescence and in the age-related diseases.
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